Clinical Trials Directory

Trials / Completed

CompletedNCT02230397

Efficacy and Tolerance Evaluation of a Topical "Revitalizing" Face Day Cream

Efficacy and Tolerance Evaluation of a Topical "Revitalizing" Face Day Cream: Comparison Within Subjects Versus Placebo

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Derming SRL · Academic / Other
Sex
Female
Age
45 Years – 65 Years
Healthy volunteers
Accepted

Summary

Aim of the study was to evaluate clinically and by non-invasive instrumental evaluations the "revitalizing" activity of a face cream applied twice a day, morning and evening, for an uninterrupted period of 8 weeks, by healthy female volunteers aged 45-55 years with face ritidosis and women aged 55-65 years not habitual user of antiage-creams. The study foresaw the comparison within subjects of the study product versus placebo (half face method). It was also aim of this study to evaluate products efficacy and cosmetic acceptability by the volunteers and tolerance both by investigator and volunteers.

Conditions

Interventions

TypeNameDescription
OTHERplantaricin a (active product)Product application: 8 weeks (one on the right and one on the left face side randomly) twice a day, in the morning and in the evening, with a mild massage
OTHERplacebo productProduct application: 8 weeks (one on the right and one on the left face side randomly) twice a day, in the morning and in the evening, with a mild massage

Timeline

Start date
2013-10-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2014-09-03
Last updated
2014-09-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02230397. Inclusion in this directory is not an endorsement.